Initiation of celiac disease is triggered in the gastrointestinal tract by transglutaminase 2 (TG2) assisted deamidation of gluten peptides. Deamidation is a side-reaction to transamidation and occurs if primary amines are absent. In contrast to deamidation, transamidation does not trigger an immune response. The aim of the study was to identify a suitable food additive that interacts with TG2 binding motives in gluten-derived peptides to prevent deamidation/transamidation. Homology modelling of alpha 2-gliadin and computational screening of compounds for their binding affinity to a common TG2 binding motive (P) QLP were done by using computational approaches followed by experimental testing of TG2 activity. A database containing 1174 poten...
BACKGROUND In celiac disease, small intestinal transglutaminase 2 causes deamidation of glutamine re...
Type 2 transglutaminase (TG2) is the main autoantigen in coeliac disease (CD), a widespread inflamma...
Coeliac disease is a multifactorial disease characterized by a dysregulated immune response to inges...
Initiation of celiac disease is triggered in the gastrointestinal tract by transglutaminase 2 (TG2) ...
Celiac disease, a chronic autoimmune enteropathy, may develop in genetically predisposed individuals...
The enzyme transglutaminase 2 (TG2) plays a crucial role in the initiation of celiac disease by cata...
AbstractActivation of small intestinal gluten-reactive CD4+ T cells is a critical event in celiac di...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
To date, a gluten-free diet is the only accepted form of therapy for coeliac disease (CD). Because o...
Abstract The surge in incidence of celiac disease (CD) is due more to environmental than to genetic ...
Celiac disease (CD) is a chronic inflammation of the small intestine triggered by the ingestion of g...
Celiac disease is a permanent intolerance to the gliadin fraction of wheat gluten and to similar bar...
AbstractRecent studies have implicated a crucial role for tissue transglutaminase (TG2) in the patho...
The enzyme microbial transglutaminase is heavily used in the food processing industries to ameliorat...
ZED1227 is a small molecule tissue transglutaminase (TG2) inhibitor. The compound selectively binds ...
BACKGROUND In celiac disease, small intestinal transglutaminase 2 causes deamidation of glutamine re...
Type 2 transglutaminase (TG2) is the main autoantigen in coeliac disease (CD), a widespread inflamma...
Coeliac disease is a multifactorial disease characterized by a dysregulated immune response to inges...
Initiation of celiac disease is triggered in the gastrointestinal tract by transglutaminase 2 (TG2) ...
Celiac disease, a chronic autoimmune enteropathy, may develop in genetically predisposed individuals...
The enzyme transglutaminase 2 (TG2) plays a crucial role in the initiation of celiac disease by cata...
AbstractActivation of small intestinal gluten-reactive CD4+ T cells is a critical event in celiac di...
Type 2 transglutaminase (TG2) is a ubiquitous enzyme able to modify gliadin peptides introduced into...
To date, a gluten-free diet is the only accepted form of therapy for coeliac disease (CD). Because o...
Abstract The surge in incidence of celiac disease (CD) is due more to environmental than to genetic ...
Celiac disease (CD) is a chronic inflammation of the small intestine triggered by the ingestion of g...
Celiac disease is a permanent intolerance to the gliadin fraction of wheat gluten and to similar bar...
AbstractRecent studies have implicated a crucial role for tissue transglutaminase (TG2) in the patho...
The enzyme microbial transglutaminase is heavily used in the food processing industries to ameliorat...
ZED1227 is a small molecule tissue transglutaminase (TG2) inhibitor. The compound selectively binds ...
BACKGROUND In celiac disease, small intestinal transglutaminase 2 causes deamidation of glutamine re...
Type 2 transglutaminase (TG2) is the main autoantigen in coeliac disease (CD), a widespread inflamma...
Coeliac disease is a multifactorial disease characterized by a dysregulated immune response to inges...